The impact of mental illness on quality of life: A comparison of severe mental illness, common mental disorder and healthy population samples

被引:0
|
作者
Sherrill Evans
Sube Banerjee
Morven Leese
Peter Huxley
机构
[1] Institute of Psychiatry,King’s College
[2] Institute of Psychiatry,Social Work and Social Care Section, Health Services Research Department, David Goldberg Centre
[3] Swansea University,Department of Applied Social Sciences
[4] David Goldberg Centre,Social Work and Social Care Section (Box 032), Health Services Research Department
[5] Institute of Psychiatry,undefined
来源
Quality of Life Research | 2007年 / 16卷
关键词
Common mental disorder; General population; Measurement; Severe mental illness; Quality of life;
D O I
暂无
中图分类号
学科分类号
摘要
Patient-centred outcomes such as quality of life (QOL) are valued and used extensively in mental healthcare evaluations, but concerns remain about their practical application due to perceived measurement issues, including responsiveness and relationships with objective indicators and depression. Evidence from general population studies challenge some assumptions, suggesting that measurement difficulties might relate to the characteristics of mental health samples, rather than measurement itself. This paper assesses the impact of mental illness on QOL and its measurement, examining whether the life-conditions, opportunities and QOL of different mental health-status groups vary, and if explanatory models of domain-specific and global QOL differ. Objective life-conditions, access to life-opportunities and subjective QOL were assessed over 2 years, using the same methodology in severe mental illness (SMI; n = 149 (baseline)/n = 126 (follow-up)), common mental disorder (CMD; n = 794/354) and no disorder (n = 1119/583) groups. Objective life-conditions were worse in the SMI group than in mentally healthy population and CMD groups, but the opportunities available to the SMI group were no more restricted than the CMD group. Subjective QOL ratings reflected this; SMI group scores were lower than the healthy population and in some life-domains the CMD group. Models of QOL suggested that life-quality was explained differently in the three groups. QOL studies combining mental health samples should control for health-status group, and domain-specific and global indicators of lifestyle and opportunity.
引用
收藏
页码:17 / 29
页数:12
相关论文
共 50 条
  • [41] Mental Health Professionals' Attitudes Towards People with Severe Mental Illness: Are they Related to Professional Quality of Life?
    Koutra, Katerina
    Mavroeides, Georgios
    Triliva, Sofia
    [J]. COMMUNITY MENTAL HEALTH JOURNAL, 2022, 58 (04) : 701 - 712
  • [42] Severe mental illness and the perimenopause
    Behrman, Sophie
    Crockett, Clair
    [J]. BJPSYCH BULLETIN, 2023,
  • [43] Severe mental illness in depression
    Möller, HJ
    Bottlender, R
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2006, 113 : 64 - 68
  • [44] Smoking and severe mental illness
    不详
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2015, 19 (25) : 1 - +
  • [45] Overview of severe mental illness
    Johnson, DL
    [J]. CLINICAL PSYCHOLOGY REVIEW, 1997, 17 (03) : 247 - 257
  • [46] YOGA AND SEVERE MENTAL ILLNESS
    Adams, Em
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2018, 52 : S64 - S64
  • [47] Severe mental illness and work
    Waghorn, Geoffrey
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2013, 47 (05): : 488 - 489
  • [48] Mental Health Professionals’ Attitudes Towards People with Severe Mental Illness: Are they Related to Professional Quality of Life?
    Katerina Koutra
    Georgios Mavroeides
    Sofia Triliva
    [J]. Community Mental Health Journal, 2022, 58 : 701 - 712
  • [49] The influence of mental illness on mental disorder of college students
    Cao, Liping
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2024, 59 (03): : 15S - 16S
  • [50] Impact of healthy lifestyle intervention group on weight gain in severe mental illness
    Hariram, J
    Ejara, AD
    Knights, L
    Lewis, E
    Hudson, S
    Bradley, J
    Reilly, J
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (03) : A52 - A52